Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
Drug Regulation01:25

Drug Regulation

1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.9K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CGM Accuracy in a Fragmented Regulatory Landscape: A Commentary on Harmonisation and Recent Evidence.

Diabetes, obesity & metabolism·2026
Same author

Quality of care for migrant populations with type 2 diabetes mellitus in Italy: a retrospective analysis of data from the the Italian AMD (Associations of Medical Diabetologists) annals initiative.

Acta diabetologica·2026
Same author

Association between electronic cigarette use and prediabetes, diabetes, and insulin resistance: a systematic review and meta-analysis.

Internal and emergency medicine·2026
Same author

Evaluation of the Safety, Efficacy and Pharmacokinetics of BGM0504 in Chinese Adults With Type 2 Diabetes: A Multicentre, Randomised, Controlled and Double-Blind Phase II Trial.

Diabetes, obesity & metabolism·2026
Same author

Causes and consequences of discontinuation of GLP1RAs or tirzepatide.

Nature reviews. Endocrinology·2026
Same author

A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial.

The lancet. Diabetes & endocrinology·2026

Related Experiment Video

Updated: Sep 24, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.7K

Guideline Development for Medical Device Technology: Issues for Consideration.

Tadej Battelino1, Frank Brosius2, Antonio Ceriello3

  • 1University Medical Center Ljubljana, University of Ljubljana, Ljubljana, Slovenia.

Journal of Diabetes Science and Technology
|May 9, 2022
PubMed
Summary

Innovative medical devices and telehealth can enhance diabetes care by leveraging health data. Current evidence grading methods need revision to keep pace with rapid technological advancements in healthcare.

Keywords:
CGMcontinuous glucose monitoringdiabetes technologiesguidelinesrandomized controlled trialsreal-world evidence

More Related Videos

Author Spotlight: Rapid Prototyping and Testing of Self-Expanding Nitinol Frames for Transcatheter Implantable Devices
06:53

Author Spotlight: Rapid Prototyping and Testing of Self-Expanding Nitinol Frames for Transcatheter Implantable Devices

Published on: March 7, 2025

453
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

2.9K

Related Experiment Videos

Last Updated: Sep 24, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.7K
Author Spotlight: Rapid Prototyping and Testing of Self-Expanding Nitinol Frames for Transcatheter Implantable Devices
06:53

Author Spotlight: Rapid Prototyping and Testing of Self-Expanding Nitinol Frames for Transcatheter Implantable Devices

Published on: March 7, 2025

453
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

2.9K

Area of Science:

  • Medical Technology
  • Diabetes Care
  • Health Informatics

Background:

  • Innovative medical devices and telehealth technologies offer potential to improve diabetes care quality and efficiency.
  • These technologies facilitate data collection, aggregation, and interpretation for informed decision-making among stakeholders.
  • Existing clinical practice guidelines for technology use often rely on evidence selection and grading methodologies that may not suit rapid innovation.

Purpose of the Study:

  • To critically evaluate current methodologies for selecting and grading evidence related to medical devices and telehealth in diabetes care.
  • To propose revisions to evidence grading processes to better accommodate the rapid pace of technological innovation.
  • To enhance the effective integration of new technologies into diabetes management.

Main Methods:

  • Review of strengths and limitations of common research types used for evidence selection and grading.
  • Analysis of existing guidelines for medical device and telehealth technology implementation.
  • Development of recommendations for modifying evidence grading processes.

Main Results:

  • Identification of challenges in applying traditional evidence grading to rapidly evolving medical technologies.
  • Discussion of the need for adaptable frameworks to assess the quality and applicability of evidence for new devices and telehealth.
  • Highlighting the gap between technological advancement and current evidence-based practice guidelines.

Conclusions:

  • Current evidence selection and grading methodologies require updates to effectively support the integration of innovative medical devices and telehealth in diabetes care.
  • Revised approaches are necessary to accurately assess the value and impact of rapidly developing technologies.
  • Adapting evidence evaluation is crucial for optimizing diabetes care in the face of continuous technological progress.